Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial

Objective This study aimed to assess the cost-effectiveness of telehealthcare in heart failure patients as add-on to usual care.Design A cost-utility analysis was conducted from a public payer perspective alongside the randomised controlled TeleCare North trial.Setting The North Denmark Region, Denm...

Full description

Saved in:
Bibliographic Details
Main Authors: Anne Sig Vestergaard, Louise Hansen, Sabrina Storgaard Sørensen, Morten Berg Jensen, Lars Holger Ehlers
Format: Article
Language:English
Published: BMJ Publishing Group 2020-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/1/e031670.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846140159219728384
author Anne Sig Vestergaard
Louise Hansen
Sabrina Storgaard Sørensen
Morten Berg Jensen
Lars Holger Ehlers
author_facet Anne Sig Vestergaard
Louise Hansen
Sabrina Storgaard Sørensen
Morten Berg Jensen
Lars Holger Ehlers
author_sort Anne Sig Vestergaard
collection DOAJ
description Objective This study aimed to assess the cost-effectiveness of telehealthcare in heart failure patients as add-on to usual care.Design A cost-utility analysis was conducted from a public payer perspective alongside the randomised controlled TeleCare North trial.Setting The North Denmark Region, Denmark.Participants The study included 274 heart failure patients with self-reported New York Heart Association class II-IV.Interventions Patients in the intervention group were provided with a Telekit consisting of a tablet, a digital blood pressure monitor, and a scale and were instructed to perform measurements one to two times a week. The responsibility of the education, instructions and monitoring of the heart failure (HF) patients was placed on municipality nurses trained in HF and telemonitoring. Both groups received usual care.Outcome measures Cost-effectiveness was reported as incremental net monetary benefit (NMB). A micro-costing approach was applied to evaluate the derived savings in the first year in the public health sector. Quality-adjusted life-years (QALY) gained were estimated using the EuroQol 5-Dimensions 5-Levels questionnaire at baseline and at a 1-year follow-up.Results Data for 274 patients were included in the main analysis. The telehealthcare solution provided a positive incremental NMB of £5164. The 1-year adjusted QALY difference between the telehealthcare solution and the usual care group was 0.0034 (95% CI: −0.0711 to 0.0780). The adjusted difference in costs was -£5096 (95% CI: −8736 to −1456) corresponding to a reduction in total healthcare costs by 35%. All sensitivity analyses showed the main results were robust.Conclusions The TeleCare North solution for monitoring HF was highly cost-effective. There were significant cost savings on hospitalisations, primary care contacts and total costs.Trial registration number ClinicalTrials.gov: NCT02860013.
format Article
id doaj-art-d796908e29364ec1b95e3ff16d7ce12f
institution Kabale University
issn 2044-6055
language English
publishDate 2020-01-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-d796908e29364ec1b95e3ff16d7ce12f2024-12-05T18:20:10ZengBMJ Publishing GroupBMJ Open2044-60552020-01-0110110.1136/bmjopen-2019-031670Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trialAnne Sig Vestergaard0Louise Hansen1Sabrina Storgaard Sørensen2Morten Berg Jensen3Lars Holger Ehlers4Danish Center for Healthcare Improvements, Department of Business and Management, Aalborg University, Aalborg Oest, DenmarkDanish Center for Healthcare Improvements, Department of Business and Management, Aalborg University, Aalborg Oest, DenmarkDanish Center for Healthcare Improvements, Department of Business and Management, Aalborg University, Aalborg Oest, DenmarkAarhus Business School, Aarhus University, Aarhus, DenmarkDanish Center for Healthcare Improvements, Department of Business and Management, Aalborg University, Aalborg Oest, DenmarkObjective This study aimed to assess the cost-effectiveness of telehealthcare in heart failure patients as add-on to usual care.Design A cost-utility analysis was conducted from a public payer perspective alongside the randomised controlled TeleCare North trial.Setting The North Denmark Region, Denmark.Participants The study included 274 heart failure patients with self-reported New York Heart Association class II-IV.Interventions Patients in the intervention group were provided with a Telekit consisting of a tablet, a digital blood pressure monitor, and a scale and were instructed to perform measurements one to two times a week. The responsibility of the education, instructions and monitoring of the heart failure (HF) patients was placed on municipality nurses trained in HF and telemonitoring. Both groups received usual care.Outcome measures Cost-effectiveness was reported as incremental net monetary benefit (NMB). A micro-costing approach was applied to evaluate the derived savings in the first year in the public health sector. Quality-adjusted life-years (QALY) gained were estimated using the EuroQol 5-Dimensions 5-Levels questionnaire at baseline and at a 1-year follow-up.Results Data for 274 patients were included in the main analysis. The telehealthcare solution provided a positive incremental NMB of £5164. The 1-year adjusted QALY difference between the telehealthcare solution and the usual care group was 0.0034 (95% CI: −0.0711 to 0.0780). The adjusted difference in costs was -£5096 (95% CI: −8736 to −1456) corresponding to a reduction in total healthcare costs by 35%. All sensitivity analyses showed the main results were robust.Conclusions The TeleCare North solution for monitoring HF was highly cost-effective. There were significant cost savings on hospitalisations, primary care contacts and total costs.Trial registration number ClinicalTrials.gov: NCT02860013.https://bmjopen.bmj.com/content/10/1/e031670.full
spellingShingle Anne Sig Vestergaard
Louise Hansen
Sabrina Storgaard Sørensen
Morten Berg Jensen
Lars Holger Ehlers
Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial
BMJ Open
title Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial
title_full Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial
title_fullStr Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial
title_full_unstemmed Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial
title_short Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial
title_sort is telehealthcare for heart failure patients cost effective an economic evaluation alongside the danish telecare north heart failure trial
url https://bmjopen.bmj.com/content/10/1/e031670.full
work_keys_str_mv AT annesigvestergaard istelehealthcareforheartfailurepatientscosteffectiveaneconomicevaluationalongsidethedanishtelecarenorthheartfailuretrial
AT louisehansen istelehealthcareforheartfailurepatientscosteffectiveaneconomicevaluationalongsidethedanishtelecarenorthheartfailuretrial
AT sabrinastorgaardsørensen istelehealthcareforheartfailurepatientscosteffectiveaneconomicevaluationalongsidethedanishtelecarenorthheartfailuretrial
AT mortenbergjensen istelehealthcareforheartfailurepatientscosteffectiveaneconomicevaluationalongsidethedanishtelecarenorthheartfailuretrial
AT larsholgerehlers istelehealthcareforheartfailurepatientscosteffectiveaneconomicevaluationalongsidethedanishtelecarenorthheartfailuretrial